These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23674149)

  • 1. Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media.
    Kluge S; Rourou S; Vester D; Majoul S; Benndorf D; Genzel Y; Rapp E; Kallel H; Reichl U
    Appl Microbiol Biotechnol; 2013 Jun; 97(12):5493-506. PubMed ID: 23674149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of epithelial cells with dengue virus promotes the expression of proteins favoring the replication of certain viral strains.
    Martínez-Betancur V; Marín-Villa M; Martínez-Gutierrez M
    J Med Virol; 2014 Aug; 86(8):1448-58. PubMed ID: 24374781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach.
    Vester D; Rapp E; Kluge S; Genzel Y; Reichl U
    J Proteomics; 2010 Aug; 73(9):1656-69. PubMed ID: 20435171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask.
    Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A
    Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression changes of cytoskeletal associated proteins in proteomic profiling of neuroblastoma cells infected with different strains of rabies virus.
    Zandi F; Eslami N; Torkashvand F; Fayaz A; Khalaj V; Vaziri B
    J Med Virol; 2013 Feb; 85(2):336-47. PubMed ID: 23168799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell].
    Shi XS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii antigens: recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium.
    da Costa-Silva TA; da Silva Meira C; Frazzatti-Gallina N; Pereira-Chioccola VL
    Exp Parasitol; 2012 Apr; 130(4):463-9. PubMed ID: 22306070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
    Vester D; Rapp E; Gade D; Genzel Y; Reichl U
    Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies virus production in high vero cell density cultures on macroporous microcarriers.
    Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA
    Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.